---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-046104"
form_type: "8-K"
ticker: null
cik: "0000727207"
company_name: "Accelerate Diagnostics, Inc"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T06:01:54.093308+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Accelerate Diagnostics files Chapter 11; Indaba to acquire assets via $36.9M credit bid

## Summary
- Filed voluntary Chapter 11 petitions in Delaware Bankruptcy Court on May 8, 2025.
- Secured $12.5M multi-draw DIP financing commitment from Indaba Capital, pending court approval.
- Stalking horse bid: Indaba to buy substantially all assets via $36.9M credit bid of its secured notes plus assumed liabilities.
- Sale subject to Section 363 auction process with court-approved bidding procedures; competing bids solicited.
- Company cautions common stock holders expect significant or complete loss on investment.

## SEC filing metadata
- accession: 0001104659-25-046104
- form_type: 8-K
- cik: 0000727207
- company_name: Accelerate Diagnostics, Inc
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 1.03, 2.03, 2.04, 7.01, 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727207/000110465925046104/0001104659-25-046104-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727207/000110465925046104/tm2514448d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-046104
- JSON: https://secwatch.observer/filing/0001104659-25-046104.json
- Plain text: https://secwatch.observer/filing/0001104659-25-046104.txt

## Key facts
- Debt Financings
  Accelerate Diagnostics, Inc faced acceleration on senior notes of 16.00% Super Priority Senior Secured PIK Notes due December 31, 2025 with U.S. Bank Trust Company, National Association at 16.00% maturing December 31, 2025.
  - Instrument: senior notes
  - Principal: 16.00% Super Priority Senior Secured PIK Notes due December 31, 2025
  - Counterparty: U.S. Bank Trust Company, National Association
  - Rate: 16.00%
  - Maturity: December 31, 2025
  - Event: acceleration
  source text: The filing of the Bankruptcy Petitions described in Item 1.03 above constitutes an event of default that accelerated the Company’s obligations under the following debt instruments (the “ Debt Instruments ”): · Indenture, dated as of August 8, 2024, by and among the Company, as issuer, and U.S. Bank Trust Company, National Association, as Trustee, governing the 16.00% Super Priority Senior Secured PIK Notes due December 31, 2025; and · Indenture, dated as of June 9, 2023, by and among the Company, as issuer, and U.S. Bank Trust Company, National Association, as trustee and collateral agent, governing the 5.00% Senior Secured Convertible Notes due December 15, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925046104/0001104659-25-046104-index.htm
- Debt Financings
  Accelerate Diagnostics, Inc faced acceleration on convertible notes of 5.00% Senior Secured Convertible Notes due December 15, 2026 with U.S. Bank Trust Company, National Association at 5.00% maturing December 15, 2026.
  - Instrument: convertible notes
  - Principal: 5.00% Senior Secured Convertible Notes due December 15, 2026
  - Counterparty: U.S. Bank Trust Company, National Association
  - Rate: 5.00%
  - Maturity: December 15, 2026
  - Event: acceleration
  source text: The filing of the Bankruptcy Petitions described in Item 1.03 above constitutes an event of default that accelerated the Company’s obligations under the following debt instruments (the “ Debt Instruments ”): · Indenture, dated as of August 8, 2024, by and among the Company, as issuer, and U.S. Bank Trust Company, National Association, as Trustee, governing the 16.00% Super Priority Senior Secured PIK Notes due December 31, 2025; and · Indenture, dated as of June 9, 2023, by and among the Company, as issuer, and U.S. Bank Trust Company, National Association, as trustee and collateral agent, governing the 5.00% Senior Secured Convertible Notes due December 15, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925046104/0001104659-25-046104-index.htm
- Distress & Bankruptcy
  Accelerate Diagnostics, Inc entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2025-05-08).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2025-05-08
  source text: on May 8, 2025 (the “ Petition Date ”), Accelerate Diagnostics, Inc. (the “ Company ”) and its US subsidiary, Accelerate Diagnostics Texas, LLC (collectively, with the Company, the “ Debtors ”), filed voluntary petitions for relief (the “ Bankruptcy Petitions ”) under Chapter 11 of the United States Code (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the District of Delaware
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925046104/0001104659-25-046104-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.